Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Immunopharmacology|February 15, 2011
Meeting report: regulatory myeloid cellsDrake LaFace, James Talmadge
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 2008
Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problemRobert D Winfield, Matthew J Delano, Kalyan Pande, et al.
Human Immunology|November 24, 2004
Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10-producing CD4+ T cellsDelphine Rea, Drake Laface, Beth Hutchins, et al.
Cancer Research|May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organsJan Emmerich, John B Mumm, Ivan H Chan, et al.
Arthritis Research & Therapy|February 20, 2010
Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursorsIannis E Adamopoulos, Cheng-Chi Chao, Richard Geissler, et al.
Journal of Endotoxin Research|December 14, 2004
Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expressionCaroline Oberholzer, Andreas Oberholzer, Sven K Tschoeke, et al.
Journal of Biotechnology|May 28, 2015
In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastorisSujatha Gomathinayagam, Drake Laface, Nga Rewa Houston-Cummings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine modelVan Tsai, Duane E Johnson, Amena Rahman, et al.
Frontiers in Immunology|December 17, 2020
Corrigendum: Effective Anti-tumor Response by TIGIT Blockade Associated With Fc<i>γ</i>R Engagement and Myeloid Cell ActivationJin-Hwan Han, Mingmei Cai, Jeffery Grein, et al.
Frontiers in Immunology|October 29, 2020
Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell ActivationJin-Hwan Han, Mingmei Cai, Jeffery Grein, et al.
Pageof 2